Price $5.06 |
Market Cap
59M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.86
|
P/S
-
|
Dividend %
-
|
|
P/CF
22.6
|
P/FCF
-
|
Op. Cash Flow
-17.7K
|
FCF
-1.5
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-76.00%
|
ROI
-
|
|
ROA
-69.50%
|
EPS Growth
12.60%
|
Current Ratio
26.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Airsculpt Technologies Inc (AIRS) | $5.50 | - | - | 339.6M | Strong Buy |
| iCAD Inc (ICAD) | $1.49 | - | - | 38.2M | Strong Buy |
| Titan Pharmaceuticals Inc (TTNP) | $6.70 | - | - | 6.5M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.00 | - | - | 12.8M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $1.51 | - | - | 28.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
